Objective: To analyze the risk factors of hyperperfusion syndrome(HPS) after intracranial artery stent implantation and establish a nomogram prediction model. Methods: A total of 200 patients who underwent intracranial artery stent implantation in our hospital from January 2020 to December 2021 were selected as the research subjects. Based on the occurrence of postoperative HPS, patients were categorized into two groups: the HPS group(n=94) and the non-HPS group(n=106). Lasso and binary Logistic regression analyses were employed to identify the influencing factors for HPS following intracranial artery stenting. A nomogram model for predicting HPS was constructed based on these findings, and the predictive performance of the model was evaluated using the area under the receiver operating characteristic curve(AUC). Results: Univariate analysis revealed statistically significant differences between the two groups in terms of age, history of hypertension, history of diabetes, degree of carotid artery stenosis, intracranial collateral circulation, and postoperative cerebral blood flow(all P<0.05). These six variables were identified as potential influencing factors following Lasso regression screening. Logistic regression analysis demonstrated that age ≥70 years, history of hypertension, history of diabetes, severe carotid artery stenosis, poor intracranial collateral circulation, and abnormal postoperative cerebral blood flow were all independent risk factors for HPS after intracranial artery stenting(all P<0.05). The AUC of the nomogram prediction model for HPS was 0.963(95% CI 0.940-0.987), with a sensitivity of 0.915 and a specificity of 0.883. Internal validation of the HPS prediction model was performed using the Bootstrap method. The bias-corrected prediction curve closely approximated the ideal curve, with a C-index of 0.927, indicating high predictive performance. Across the threshold probability range of 0 to 1, the model consistently demonstrated a positive net benefit, and its performance surpassed that of both comparative null lines. Conclusion: Age ≥70 years, history of hypertension, history of diabetes, severe carotid artery stenosis, poor intracranial collateral circulation, and abnormal postoperative cerebral blood flow are high-risk factors for HPS following intracranial artery stenting. Clinical care should focus on and strengthen preventive measures targeting these factors. |
[1] 张勇,吕鸿燕,李苇,等.自膨胀式支架置入术治疗颅内动脉粥样硬化性狭窄术后再狭窄危险因素分析[J].中国临床神经科学,2024,32(6):656-662,704.
[2] 孙博文,凌冶平,吴培,等.颅内动脉粥样硬化性狭窄自膨胀式支架治疗术后不良事件及再狭窄的危险因素分析[J].中国脑血管病杂志,2023,20(3):159-167,211.
[3] ZUPAN M,PEROVNIK M,PRETNAR OBLAK J,et al.Post-carotid artery stenting hyperperfusion syndrome in a hypotensive patient:case report and systematic review of literature[J].Life(Basel),2024,14(11):1472.
[4] 葛慧剑,桂思铭,邓丁伟,等.颅内未破裂动脉瘤Pipeline栓塞装置置入术后支架内狭窄的危险因素[J].中国临床神经外科杂志,2023,28(7):429-432.
[5] 冯凡凡,杨洪超,阚伟豪,等.大血管闭塞性卒中病人脑白质高信号严重程度与侧支循环的关系[J].安徽医药,2024,28(6):1176-1181.
[6] 王修宇,刘华坤,初建峰.重度有症状颅内段颈动脉狭窄患者支架内再狭窄的危险因素[J].国际脑血管病杂志,2024,32(4):254-259.
[7] UCHIDA K,SAKAKIBARA F,SAKAI N,et al.Real-world outcomes of carotid artery stenting in symptomatic and asymptomatic patients with carotid artery stenosis[J].JACC Cardiovasc Interv,2024,17(9):1148-1159.
[8] LECLERC A,GOIA A,GILARD V,et al.Massive non-aneurysmal subarachnoid hemorrhage after cervical carotid angioplasty and stenting:a case report and review of the literature[J].Neurochirurgie,2022,68(3):342-346.
[9] 路红燕,孟文娟,张素霞.颅内动脉支架置入术患者创伤后应激障碍水平与疾病感知控制及社会支持的相关性研究[J].现代医学,2025,53(1):63-68.
[10] 丁建东,徐荣丰,张晓黎,等.经颈静脉入路行经导管肺动脉瓣置换术治疗重度肺动脉瓣反流一例[J].东南大学学报(医学版),2023,42(5):759-763.
[11] WANG J,ZHENG H,HU F.Fatal immediate intra operative hemorrhage during middle cerebral artery stenting[J].J Neuroradiol,2023,50(6):602.
[12] TSUBOKI S,MIZUNO T.Focal non-aneurysmal subarachnoid hemorrhage after carotid artery stenting:a case report[J].Cureus,2024,16(6):e62104.
[13] 张素霞,刘俊英,孟文娟,等.优质护理服务在颅内动脉狭窄支架置入术患者护理中的效果研究[J].生命科学仪器,2023,21(S1):171.
[14] FAN X,LAI Z,LIN T,et al.Multidelay MR arterial spin labeling perfusion map for the prediction of cerebral hyperperfusion after carotid endarterectomy[J].J Magn Reson Imaging,2023,58(4):1245-1255.
[15] WANG T,YANG K,ZHANG X,et al.Endovascular therapy for symptomatic intracranial artery stenosis:a systematic review and network meta-analysis[J].Transl Stroke Res,2022,13(5):676-685.
[16] 李福荣,刘书含,董薇薇,等.脑过度灌注综合征[J].国际脑血管病杂志,2024,32(4):297-302.
[17] 吴建明,马斌武,吴艳蓉,等.颈动脉支架置入术后脑高灌注综合征的危险因素分析及预防措施[J].临床放射学杂志,2023,42(5):831-836.
[18] 杨晓敏,魏琳,叶日春,等.颈动脉支架成形术后高灌注综合征危险因素的Meta分析[J].神经损伤与功能重建,2023,18(8):450-455.
[19] PIPER K,FAROOQ J,YEUNG E,et al.Transcarotid artery revascularization(TCAR) stenting or angioplasty for intracranial carotid artery stenosis:case series and novel application[J].Interv Neuroradiol,2023,29(4):351-357.
[20] 范晓媛,有慧,冯逢.脑过度灌注综合征的影像学研究进展[J].国际医学放射学杂志,2023,46(5):543-546,550.
[21] 王铭义,刘永晟,吴邯,等.血流导向装置治疗颅内动脉瘤术后脑高灌注综合征一例[J].中国脑血管病杂志,2022,19(7):498-500.
[22] SUN X,WU X,YANG M,et al.Comprehensive assessment of drug kinetics,neurotoxicity,and safety of sirolimus-eluting intracranial stents in canine basilar artery[J].Neurosurgery,2024,95(5):1199-1208.
[23] 董利萍,陈思,张晓燕.颅内外大血管急性开通后高灌注综合征预测研究进展[J].中国实用神经疾病杂志,2022,25(9):1173-1177.
[24] 吴明洪,徐海涛,黄书岚.脑底异常血管网症血流重建术后并发脑高灌注综合征的危险因素[J].中国临床神经外科杂志,2024,29(8):495-498. |